The 2nd International iFIT Conference aims to strengthen the global cancer research community by fostering scientific excellence, interdisciplinary collaboration, and translational innovation.
The conference will highlight recent advances in:
- Functional target discovery and precision oncology
- Academic drug discovery and development
- Cancer immunotherapy and immune engineering
- Molecular and functional imaging technologies
- Artificial intelligence and computational approaches in oncology
- Translational research and early clinical implementation
Together, these areas illustrate how integrated research can accelerate the development of personalized cancer therapies.
Scientific sessions will focus on some of the most pressing challenges in oncology, including:
- Understanding and overcoming therapy resistance
- Identifying novel therapeutic vulnerabilities
- Improving patient stratification and treatment personalization
- Developing next-generation immunotherapies
- Advancing imaging-guided therapeutic strategies
- Accelerating the translation of laboratory discoveries into clinical benefit
A central objective of the conference is to create new opportunities for collaboration across disciplines, institutions, and sectors. By bringing together experts from academia, clinical medicine, industry, and technology development, the meeting will foster partnerships that enable innovative research projects, shared infrastructures, and future translational initiatives.
The conference emphasizes the complete innovation pathway, from basic discovery and target identification through drug and diagnostic development to early clinical evaluation. Discussions will showcase how interdisciplinary research can accelerate the development of new therapies and diagnostics that ultimately improve outcomes for patients with cancer.
Investing in early-career researchers is a core element of the conference. Through scientific presentations, poster sessions, mentoring opportunities, and networking activities, students, doctoral candidates, postdoctoral researchers, and clinician scientists will gain visibility, receive expert feedback, and establish connections with leading international researchers and industry partners.
By encouraging scientific exchange across career stages and disciplines, the conference aims to inspire future collaborations and support the development of the next generation of leaders in cancer research.